MedTrace Logo

Implantable Long-Acting Pre-Exposure Prophylaxis For MSM

NCT05420207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2025-10-24

No results posted yet for this study

Summary

The long-term goal of this project is to better understand factors at the patient and physician level that can be addressed to impact uptake of long-acting, implantable PrEP (LA-PrEP) products in the future and identify the training needs of physicians. This project specifically focuses on men who have sex with men (MSM) seen in primary care settings in Texas. The main objective of this project is to examine perspectives of MSM and physicians in Texas regarding LA-PrEP, including attitudes and barriers to use and implementation by interviewing patients and physicians from the same clinical practices.

Conditions

  • HIV Prevention

Interventions

OTHER

No intervention

No intervention included

Sponsors & Collaborators

Principal Investigators

  • Elizabeth Arnold, PhD · University of Kentucky

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-14
Primary Completion
2025-09-05
Completion
2025-09-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05420207 on ClinicalTrials.gov